These bacteria help break down food, support digestion, and produce certain chemicals that leave the body through stool, breath, or urine
Additionally, GLP-1RAs slow gastric emptying, enhancing the feeling of fullness and reducing overall caloric intake, making them effective for weight management
As of our 2025 comparison, Wegovy (semaglutide) and Zepbound (tirzepatide) are the brand names specifically FDA-approved for chronic weight management
Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it targets two incretin pathways simultaneously
Its available at Ness as a compounded medication made by a licensed U.S
TREATMENT COST Starts at $350 $500 per month (Please contact us for custom bundle pricing)